cgp 54626 has been researched along with guanylyl imidodiphosphate in 2 studies
| Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (guanylyl imidodiphosphate) | Trials (guanylyl imidodiphosphate) | Recent Studies (post-2010) (guanylyl imidodiphosphate) |
|---|---|---|---|---|---|
| 57 | 0 | 16 | 2,356 | 1 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernasconi, R; Bittiger, H; De Barry, J; Marescaux, C; Mathivet, P | 1 |
| Green, A; Green, RH; Marshall, FH; Martin, AK; Walls, S; Wise, A | 1 |
2 other study(ies) available for cgp 54626 and guanylyl imidodiphosphate
| Article | Year |
|---|---|
Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
Topics: Animals; Anticonvulsants; Baclofen; Binding, Competitive; Brain Chemistry; Ethosuximide; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Organophosphorus Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-B; Sodium Oxybate; Valproic Acid | 1997 |
Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA(B) receptors stably expressed in mammalian cells.
Topics: Animals; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Dimerization; Dose-Response Relationship, Drug; GABA Agonists; GABA Antagonists; Gene Expression; Guanylyl Imidodiphosphate; Humans; Immunoblotting; Kinetics; Organophosphorus Compounds; Radioligand Assay; Receptors, GABA-B; Tritium | 2000 |